SCHEMBL60503

SCHEMBL60503

CC1(C(=O)O)CCCCCC1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.72
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP2C19 P33261 2/20 0.42
CETP P11597 2/20 0.36
P2RX7 Q99572 1/20 0.35
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
AKR1C1 Q04828 1/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
BLM P54132 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CCR2 P41597 1/20 0.33
HSD11B1 P28845 1/20 0.33
POLB P06746 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13075127 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL10268820 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL11922843 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL19322861 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL13341342 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL18449 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL25213839 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL14627497 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL13075808 1.00 FFAR3 (0.72) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP
SCHEMBL6915756 0.97 FFAR3 (0.68) FFAR3ALDH1A1SMN1; SMN2CYP2C19CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174633-A1 PYRAZOLE COMPOUNDS SELECTIVE FOR NEUROTENSIN 2 RECEPTOR NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2017-06-22 US disclosed
US-9446021-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof DOGWOOD PHARMACEUTICALS, INC. (US) 2016-09-20 US disclosed
US-20150313873-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof DOGWOOD PHARMACEUTICALS, INC. 2015-11-05 US disclosed
US-9120754-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof DOGWOOD PHARMACEUTICALS, INC. (US) 2015-09-01 US disclosed
US-8592071-B2 Laminated porous film and separator for battery MITSUBISHI PLASTICS, INC. (JP) 2013-11-26 US disclosed
CN-101952295-B Pyrrolopyrazine kinase inhibitors HOFFMANN LA ROCHE 2013-11-20 CN disclosed
EP-1860712-B1 POROUS FILM CARRYING REACTIVE POLYMER FOR SEPARATOR FOR USE IN CELL NITTO DENKO CORP (JP) 2012-10-10 EP disclosed
US-8277968-B2 Reactive polymer-supporting porous film for battery separator and use thereof NITTO DENKO CORPORATION (JP) 2012-10-02 US disclosed
US-20120129837-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof ALLERGAN SALES, LLC 2012-05-24 US disclosed
US-8129519-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof ALLERGAN SALES, LLC 2012-03-06 US disclosed
US-5716998-A PARTICLES COMPRISING POLYPROPYLENE RESIN AND DIAMIDE COMPOUND AS BETA-FORM NUCLEATING AGENT KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1998-02-10 US disclosed
EP-0802730-A1 PESTICIDAL COMPOUNDS BTG INTERNATIONAL LIMITED (GB) 1997-10-29 EP disclosed
EP-0790262-A1 PROPYLENE-ETHYLENE COPOLYMER COMPOSITIONS AND PROCESS FOR THE PRODUCTION THEREOF CHISSO CORPORATION (JP) 1997-08-20 EP disclosed
EP-0790275-A1 PREFOAMED PARTICLES OF POLYPROPYLENE RESIN AND PROCESS FOR PRODUCING THE SAME KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1997-08-20 EP disclosed
EP-0776933-A1 Polybutene-1 resin composition and a method of accelerating the crystal transformation NEW JAPAN CHEMICAL CO.,LTD. (JP) 1997-06-04 EP disclosed
WO-1996021355-A1 PESTICIDAL COMPOUNDS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-07-18 WO disclosed
US-5491188-A ADDING DIAMIDE COMPOUNDS AS NUCLEATING AGENT TO PROPYLENE HOMO-, CO- AND TERPOLYMERS; FILTRATION MEMBRANES, PRINTING SHEETS NEW JAPAN CHEMICAL CO., LTD. (JP) 1996-02-13 US disclosed
CN-1098725-A Based on porous stretched article of acrylic resin and preparation method thereof NEW JAPAN CHEM CO LTD (JP) 1995-02-15 CN disclosed
EP-0632095-A2 Porous stretched article of polypropylene-based resin and process for its preparation NEW JAPAN CHEMICAL CO.,LTD. (JP) 1995-01-04 EP disclosed
EP-0557721-A2 Crystalline polypropylene resin composition and amide compounds NEW JAPAN CHEMICAL CO.,LTD. (JP) 1993-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129837-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof WNT1, CTNND1, CTNNB1 FFAR3 3490/4885ALDH1A1 1583/4885SMN1; SMN2 4091/4885
US-20150313873-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof WNT1, CTNND1, CTNNB1 FFAR3 3490/4885ALDH1A1 1583/4885SMN1; SMN2 4091/4885
US-20170174633-A1 PYRAZOLE COMPOUNDS SELECTIVE FOR NEUROTENSIN 2 RECEPTOR NTSR2, NTSR1, NPFFR2 FFAR3 355/4885ALDH1A1 3651/4885SMN1; SMN2 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.